Paul Joseph Van Damme - Net Worth and Insider Trading
Paul Joseph Van Damme Net Worth
The estimated net worth of Paul Joseph Van Damme is at least $573 dollars as of 2024-09-21. Paul Joseph Van Damme is the Director of XORTX Therapeutics Inc and owns about 232 shares of XORTX Therapeutics Inc (TSXV:XRTX) stock worth over $573. Details can be seen in Paul Joseph Van Damme's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Joseph Van Damme has not made any transactions after 2018-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Joseph Van Damme
Paul Joseph Van Damme Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Joseph Van Damme owns 1 companies in total, including XORTX Therapeutics Inc (TSXV:XRTX) .
Click here to see the complete history of Paul Joseph Van Damme’s form 4 insider trades.
Insider Ownership Summary of Paul Joseph Van Damme
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:XRTX | XORTX Therapeutics Inc | 2018-08-31 | Director |
Paul Joseph Van Damme Latest Holdings Summary
Paul Joseph Van Damme currently owns a total of 1 stock. Paul Joseph Van Damme owns 232 shares of XORTX Therapeutics Inc (TSXV:XRTX) as of August 31, 2018, with a value of $573.
Latest Holdings of Paul Joseph Van Damme
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:XRTX | XORTX Therapeutics Inc | 2018-08-31 | 232 | 2.47 | 573 |
Holding Weightings of Paul Joseph Van Damme
Paul Joseph Van Damme Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Joseph Van Damme has made a total of 0 transactions in XORTX Therapeutics Inc (TSXV:XRTX) over the past 5 years. The most-recent trade in XORTX Therapeutics Inc is the acquisition of 71 shares on August 31, 2018, which cost Paul Joseph Van Damme around $158,490.
Insider Trading History of Paul Joseph Van Damme
- 1
Paul Joseph Van Damme Trading Performance
GuruFocus tracks the stock performance after each of Paul Joseph Van Damme's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Joseph Van Damme is -8.33%. GuruFocus also compares Paul Joseph Van Damme's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Joseph Van Damme within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Joseph Van Damme's insider trading performs compared to the benchmark.
Performance of Paul Joseph Van Damme
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5 | | | | | |
| Relative Return to S&P 500(%) | -5.45 | | | | | |
Paul Joseph Van Damme Ownership Network
Paul Joseph Van Damme Owned Company Details
What does XORTX Therapeutics Inc do?
Who are the key executives at XORTX Therapeutics Inc?
Paul Joseph Van Damme is the Director of XORTX Therapeutics Inc. Other key executives at XORTX Therapeutics Inc include Director & Senior Officer Allen Warren Davidoff , Senior Officer Amar Deep Keshri , and Senior Officer James Neville Fairbairn .
XORTX Therapeutics Inc (TSXV:XRTX) Insider Trades Summary
Over the past 18 months, Paul Joseph Van Damme made no insider transaction in XORTX Therapeutics Inc (TSXV:XRTX). Other recent insider transactions involving XORTX Therapeutics Inc (TSXV:XRTX) include a net purchase of 21,200 shares made by Allen Warren Davidoff ,
In summary, during the past 3 months, insiders sold 0 shares of XORTX Therapeutics Inc (TSXV:XRTX) in total and bought 3,000 shares, with a net purchase of 3,000 shares. During the past 18 months, 0 shares of XORTX Therapeutics Inc (TSXV:XRTX) were sold and 21,200 shares were bought by its insiders, resulting in a net purchase of 21,200 shares.
XORTX Therapeutics Inc (TSXV:XRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
XORTX Therapeutics Inc Insider Transactions
Paul Joseph Van Damme Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Joseph Van Damme. Currently GuruFocus does not have mailing address information for Paul Joseph Van Damme.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
